ASCO 2017- Denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease - 101867

Spotlight
Video

ASCO 2017- Denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease

Loading........
Description: Impact of denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease
Shared By : InternationalMyelomaFoundation
Posted on : 08/15/17
Added : 8 months ago
Category : Multiple Myeloma